Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease
Open Access
- 15 February 2003
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (4) , 1228-1236
- https://doi.org/10.1523/jneurosci.23-04-01228.2003
Abstract
Parkinson9s disease (PD) is characterized by a progressive degeneration of the nigrostriatal dopaminergic pathway resulting in movement disorders. Although its etiology remains unknown, PD may be the final outcome of interactions among multiple factors, including exposure to environmental toxins and the occurrence of inflammation in the brain. In this study, using primary mesencephalic cultures, we observed that nontoxic or minimally toxic concentrations of the pesticide rotenone (0.5 nm) and the inflammogen lipopolysaccharide (LPS) (0.5 ng/ml) synergistically induced dopaminergic neurodegeneration. The synergistic neurotoxicity of rotenone and LPS was observed when the two agents were applied either simultaneously or in tandem. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species appeared to be a key contributor to the synergistic dopaminergic neurotoxicity. This conclusion was based on the following observations. First, inhibition of NADPH oxidase or scavenging of free radicals afforded significant neuroprotection. Second, rotenone and LPS synergistically stimulated the NADPH oxidase-mediated release of the superoxide free radical. Third and most importantly, rotenone and LPS failed to induce the synergistic neurotoxicity as well as the production of superoxide in cultures from NADPH oxidase-deficient animals. This is the first demonstration that low concentrations of a pesticide and an inflammogen work in synergy to induce a selective degeneration of dopaminergic neurons. Findings from this study may be highly relevant to the elucidation of the multifactorial etiology of PD and the discovery of effective therapeutic agents for the treatment of the disease.Keywords
This publication has 33 references indexed in Scilit:
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASESAnnual Review of Neuroscience, 1999
- ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASEAnnual Review of Neuroscience, 1999
- Postencephalitic parkinsonism - a reviewJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathyAnnals of Neurology, 1998
- Microglia: a sensor for pathological events in the CNSTrends in Neurosciences, 1996
- ALS, SOD and peroxynitriteNature, 1993
- 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particlesBiochemical and Biophysical Research Communications, 1990
- Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Trauma as an etiology of parkinsonism: A historical review of the conceptMovement Disorders, 1988